Anti-MARCHF10 monoclonal antibody

Pre-made anti-MARCHF10 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MARCHF10/MARCHF10 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2589-Ab-1/ GM-Tg-hg-IP2589-Ab-2Anti-Human MARCHF10 monoclonal antibodyHuman
GM-Tg-rg-IP2589-Ab-1/ GM-Tg-rg-IP2589-Ab-2Anti-Rat MARCHF10 monoclonal antibodyRat
GM-Tg-mg-IP2589-Ab-1/ GM-Tg-mg-IP2589-Ab-2Anti-Mouse MARCHF10 monoclonal antibodyMouse
GM-Tg-cynog-IP2589-Ab-1/ GM-Tg-cynog-IP2589-Ab-2Anti-Cynomolgus/ Rhesus macaque MARCHF10 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2589-Ab-1/ GM-Tg-felg-IP2589-Ab-2Anti-Feline MARCHF10 monoclonal antibodyFeline
GM-Tg-cang-IP2589-Ab-1/ GM-Tg-cang-IP2589-Ab-2Anti-Canine MARCHF10 monoclonal antibodyCanine
GM-Tg-bovg-IP2589-Ab-1/ GM-Tg-bovg-IP2589-Ab-2Anti-Bovine MARCHF10 monoclonal antibodyBovine
GM-Tg-equg-IP2589-Ab-1/ GM-Tg-equg-IP2589-Ab-2Anti-Equine MARCHF10 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2589-Ab-1/ GM-Tg-hg-IP2589-Ab-2; GM-Tg-rg-IP2589-Ab-1/ GM-Tg-rg-IP2589-Ab-2;
GM-Tg-mg-IP2589-Ab-1/ GM-Tg-mg-IP2589-Ab-2; GM-Tg-cynog-IP2589-Ab-1/ GM-Tg-cynog-IP2589-Ab-2;
GM-Tg-felg-IP2589-Ab-1/ GM-Tg-felg-IP2589-Ab-2; GM-Tg-cang-IP2589-Ab-1/ GM-Tg-cang-IP2589-Ab-2;
GM-Tg-bovg-IP2589-Ab-1/ GM-Tg-bovg-IP2589-Ab-2; GM-Tg-equg-IP2589-Ab-1/ GM-Tg-equg-IP2589-Ab-2
Products NameAnti-MARCHF10 monoclonal antibody
Formatmab
Target NameMARCHF10
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MARCHF10 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2589-Ag-1Recombinant multi-species MARHA/ MARCHF10/ MARCH-X protein


    Target information

    Target IDGM-IP2589
    Target NameMARCHF10
    Gene ID162333,632687,303596,716714,490914,101082356,540263,100064936
    Gene Symbol and Synonyms4933417C16Rik,MARCH-X,MARCH10,MARCHF10,RGD1311692,RNF190
    Uniprot AccessionQ8NA82,Q5XIV2
    Uniprot Entry NameMARHA_HUMAN,MARHA_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000173838
    Target ClassificationN/A

    The target: MARCHF10, gene name: MARCHF10, also named as MARCH-X, RNF190. MARCH10 is a member of the MARCH family of membrane-bound E3 ubiquitin ligases (EC 6.3.2.19). MARCH enzymes add ubiquitin (see MIM 191339) to target lysines in substrate proteins, thereby signaling their vesicular transport between membrane compartments (Morokuma et al., 2007 [PubMed 17604280]).[supplied by OMIM, Apr 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.